Trump acknowledges that an Executive Order to reconsider marijuana's classification is being evaluated.

Written by Emily J. Thompson, Senior Investment Analyst

Source: SeekingAlpha

Updated: Dec 15 2025

0mins

Source: SeekingAlpha

Trump's Potential Executive Order: President Trump is considering an Executive Order to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act, which would facilitate medical research and provide financial benefits for cannabis businesses.
Impact on Cannabis Industry: While this reclassification would not legalize marijuana federally, it would allow for increased testing of its medical benefits and potentially improve the financial landscape for marijuana-related companies.
Market Reaction: The news has led to a positive response in the cannabis stock market, with companies like Ascend Wellness, Curaleaf, and Green Thumb Industries seeing increased interest.
Cannabis ETFs: Various cannabis-focused exchange-traded funds (ETFs) such as AdvisorShares Pure Cannabis ETF and Amplify Alternative Harvest ETF are also impacted by the developments in the cannabis sector.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.